Press Release

Antifungals Market to Reach $10.8 Billion by 2017

January 19th, 2012

Global Information Inc. would like to present a new market research report, "Antifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth" by GBI Research.

The global Antifungals Market will grow at a moderate rate due to the impact of generic erosion in the dermatophytosis and candidiasis markets. There is no dominant player in the market, which is highly fragmented. Although it was worth $9.4 billion in 2010, the majority of revenues came from generic products and not from the branded products.

A high diagnosis rate is a driver for market growth. Current diagnostic techniques involve self diagnosis, fungal culture, microscopy and Enzyme-Linked Immunosorbent Assay (ELISA) tests, for which sensitivity and accuracy is not very high. Advances in the form of beta glucan tests and aspergillus GM EIA (Galactomannan Enzyme Immunoassay) as well as increased patient awareness will increase diagnosis rates, further supporting market growth. Untapped market can only be accessed if the treatment seeking and diagnosis rates improve.



Global Information Inc.(GII) - specializing in market research provision for the vertical industries, GII offers expert independent recommendations of publications from hundreds of the globe's leading market research firms.

Product Code : 227861